Guardian Pharmacy Services, Inc.

GRDN • Medical - Care Facilities

$40.77

▲ +0.64 (+1.59%)

Precio actual

ResultadosÚltimo reporte: 30 jun 2026

PERFIL EQUILIBRADONeutralConfianza: 70%

Perfil cuantitativo — no constituye una recomendación de inversión.

Perfil cuantitativo — no constituye una recomendación de inversión.Metodología

Tesis del análisis: Perfil mixto. La empresa no es necesariamente mala, pero la valoración, el crecimiento o el balance todavía no justifican una señal más fuerte.

Capitalización

$2.60B

Crecimiento

13.0%

Flujo de caja

5/5

Tendencia

Stable

Evidencia

Crecimiento positivo de ingresos · 15.6%Flujo de caja libre positivo · 1.29Flujo de caja libre consistente · 5/5Nivel de deuda manejable · 0.18Liquidez saludable · 1.38

Datos financieros hasta: 30 jun 2026, 12:00 a.m. UTCÚltima actualización de earnings: 30 jun 2026, 12:00 a.m. UTCÚltima actualización del perfil: 7 ago 2026, 12:56 p.m. UTC

Resumen de la compañía

Valoración, calidad, fortaleza financiera, momentum y datos de analistas.

Price$40.77

Change1.59%

Shares Out63.84M

Market Cap$2.60B

Enterprise Value$2.52B

52W Range19.30 - 44.00

Beta0.10

P/E39.49

P/S1.78

P/B10.10

P/FCF32.20

EV/Sales1.72

Price$40.77

Change1.59%

Shares Out63.84M

Market Cap$2.60B

Enterprise Value$2.52B

52W Range19.30 - 44.00

Beta0.10

P/E39.49

P/S1.78

P/B10.10

P/FCF32.20

EV/Sales1.72

EV/EBITDA21.25

EV/FCF31.18

Earnings Yield2.53%

FCF Yield3.11%

Dividend Yield0.00%

Gross Margin19.47%

Oper. Margin6.14%

Profit Margin3.40%

Debt/Eq0.18

Current Ratio1.38

Quick Ratio1.11

Revenue 5Y13.01%

FCF 5Y12.90%

Target$45.33

Target Upside11.18%

Target Median$47.00

Target Range40.00 - 49.00

Volume235.48K

Avg Volume413.67K

EPS Surprise0.05

ADN de inversión

Qué tan fuerte luce esta compañía para inversionistas de largo plazo

de 100

Calidad del negocio

Márgenes, ventaja competitiva, retornos

43/100

Fortaleza financiera

Deuda, caja, estabilidad

85/100

Potencial de crecimiento

Ingresos y expansión

95/100

Atractivo del precio

Barata o cara hoy

54/100

Por qué este puntaje▼

Crecimiento positivo de ingresos · 15.6%Flujo de caja libre positivo · 1.29Flujo de caja libre consistente · 5/5Nivel de deuda manejable · 0.18Liquidez saludable · 1.38Múltiplo de ganancias caro · 38.14

Analyst view

Analyst sentiment and price target

GRDN

Analyst sentiment

Based on 4 analyst votes · 2026-09-05

100/100

Bullish

Hold

Bearish

Precio objetivo

2026-08-07

Bajo

$40.00

Promedio

$43.50

Mediana

$43.50

Alto

$47.00

Resumen de la compañía

IPO: 9/26/2024

Industria: Medical - Care Facilities

P/B i: 10.10

Deuda / Patrimonio i: 0.18

Margen operativo: 6.14%

Margen neto: 3.40%

ROE i: -

ROIC: -

Salud financiera

Puntaje17 / 20

Deuda / Patrimonio: 0.18

Ratio corriente: 1.38

Ratio rápido: 1.11

Estado: Strong

Transacciones internas

Actividad reciente de ejecutivos e insiders

Patchett Mary Sue

Transacción: 05/05/2026

COMPRA

Cambio

+4,028

Precio

Not reported

Presentación

05/07/2026

Tipo

COMPRA

LEWIS RANDALL J

Transacción: 05/05/2026

COMPRA

Cambio

+4,028

Precio

Not reported

Presentación

05/07/2026

Tipo

COMPRA

COSLER STEVEN D

Transacción: 05/05/2026

COMPRA

Cambio

+4,028

Precio

Not reported

Presentación

05/07/2026

Tipo

COMPRA

Insider	Tipo	Cambio	Precio	Transacción	Presentación
Patchett Mary Sue	COMPRA	+4,028	Not reported	05/05/2026	05/07/2026
LEWIS RANDALL J	COMPRA	+4,028	Not reported	05/05/2026	05/07/2026
COSLER STEVEN D	COMPRA	+4,028	Not reported	05/05/2026	05/07/2026
Weir Robert	OTRO	+23,450	Not reported	04/01/2026	04/13/2026
Tuch Jeffrey	OTRO	+55,578	Not reported	04/01/2026	04/13/2026
Tuch Jeffrey	OTRO	+25,000	$34.59	04/01/2026	04/13/2026
Weir Robert	OTRO	+25,000	$34.59	04/01/2026	04/13/2026
Weir Robert	OTRO	0	Not reported	04/01/2026	04/13/2026
Tuch Jeffrey	OTRO	0	Not reported	04/01/2026	04/13/2026
Crisafulli Chris	OTRO	+18,931	Not reported	04/01/2026	04/13/2026
Crisafulli Chris	OTRO	+25,000	$34.59	04/01/2026	04/13/2026
Crisafulli Chris	OTRO	0	Not reported	04/01/2026	04/13/2026
Martin David Norman	OTRO	+25,000	$34.59	04/01/2026	04/13/2026
Martin David Norman	OTRO	+39,865	Not reported	04/01/2026	04/13/2026
Martin David Norman	OTRO	0	Not reported	04/01/2026	04/13/2026
Towns Douglas	OTRO	+25,000	$34.59	04/01/2026	04/13/2026
Towns Douglas	OTRO	+23,450	Not reported	04/01/2026	04/13/2026
Towns Douglas	OTRO	0	Not reported	04/01/2026	04/13/2026
Mudd William Franklin	OTRO	+38,282	Not reported	04/01/2026	04/13/2026
Mudd William Franklin	OTRO	+25,000	$34.59	04/01/2026	04/13/2026

Sobre la compañía

Guardian Pharmacy Services, Inc.

Guardian Pharmacy Services, Inc. operates as a pharmaceutical service provider, delivering an extensive array of tech-driven solutions. These services are specifically crafted to enhance the care of residents within long-term health care facilities (LTCFs) across the United States. The company specializes in offering personalized clinical assistance, efficient drug distribution, and comprehensive administrative support. These provisions are particularly beneficial for individuals in less acute long-term care environments, such as assisted living communities, behavioral health centers, and group homes. To bolster its operations, the company offers Guardian Compass, a platform that generates insightful dashboards from its extensive data warehouse. This tool enables its network of local pharmacies to effectively strategize, monitor performance, and refine their business processes. Furthermore, Guardian Pharmacy Services develops dedicated GuardianShield Programs for LTCFs. The company was established in 2003 and is based in Atlanta, Georgia.

Fuente - Link

Competidores

EWTX JANX MD MESO NHC NUVB PRCT QDEL TWST TXG

Tamaño = capitalización · color = línea del gráfico

Rendimiento de peers · 1A

Top performers + empresa seleccionada

Ultimas Noticias

Guardian Pharmacy Services Acquires Assets of Tennessee-Based Nautilus Pharmacy

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) has acquired assets from Tennessee-based Nautilus Pharmacy.

Business Wire

Guardian Pharmacy Services, Inc. $GRDN Shares Purchased by Bank of America Corp DE

Bank of America Corp DE increased its position in shares of Guardian Pharmacy Services, Inc. (NYSE: GRDN) by 86.1% in the quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 128,048 shares of the company's stock after purchasing an additional 59,245 shares during the

Defense World

Guardian Pharmacy Services, Inc., to Participate in Upcoming Jefferies Healthcare Services Investor Conference

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) today announced that it will participate in the Jefferies Healthcare Services Conference, on Tuesday, September 15, 2026. Fred Burke, President and Chief Executive Officer, will participate in a fireside chat at 2:25 p.m. Central Standard Time that same day. Investors, analysts, members of the media and the general public are invited to listen to a live audio webcast of the presentation accessible through Guardian Pharmacy.

Business Wire

Guardian Pharmacy Services Q2 Earnings Call Highlights

Guardian Pharmacy Services NYSE: GRDN reported second-quarter revenue growth of 2% year over year to $351.2 million, while adjusted EBITDA increased 19% to $29.7 million, as the company said it continued to offset profitability pressure from Inflation Reduction Act-related drug pricing reductions.

MarketBeat

Guardian Pharmacy Services, Inc. (GRDN) Q2 2026 Earnings Call Transcript

Seeking Alpha

Sorpresas de ganancias

Período	Estimado	Real	Sorpresa
2026-05-06	0.24	0.29	0.05
2026-03-11	0.27	0.37	0.1
2025-11-10	0.24	0.25	0.01
2025-08-11	0.22	0.23	0.01
2025-05-12	0.22	0.21	-0.01
2025-03-26	0.21	0.24	0.03
2024-11-12	0.19	-2	-2.19